ClinicalTrials.gg
Enrolling by invitationNCT07889869Updated Oct 22, 2026

Ultrasound-Guided Versus Landmark-Guided Pudendal Block for Post-Hemorrhoidectomy Pain

An interventional study of Ultrasound-Guided Pudendal Nerve Block and Landmark-Guided Pudendal Nerve Block in Hemorrhoids, Postoperative Pain and Pudendal Nerve Block, sponsored by Konya City Hospital. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Konya City Hospital · Not applicable, Interventional, and Treatment

Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Hemorrhoid surgery is often followed by significant pain during the first few days after the operation. Pudendal nerve block is a pain-control technique that can help reduce discomfort after surgery. This study will compare two different methods of performing a pudendal nerve block: an ultrasound-guided method and a conventional landmark-guided method.

Patients undergoing Milligan-Morgan hemorrhoidectomy will be randomly assigned to one of the two techniques. The study will evaluate postoperative pain levels, pain medication use, treatment-related complications, and patient satisfaction.

The study hypothesis is that the ultrasound-guided technique may provide better pain relief and reduce the need for additional pain medication compared with the landmark-guided technique.

Read the detailed description

Hemorrhoidal disease is one of the most common benign anorectal disorders worldwide. Milligan-Morgan hemorrhoidectomy remains one of the most effective surgical treatments for advanced hemorrhoidal disease; however, postoperative pain continues to be a major limitation of the procedure. Pain after hemorrhoidectomy may delay mobilization, increase analgesic requirements, prolong recovery, and negatively affect patient satisfaction.

Several pharmacological and regional analgesic techniques have been investigated to improve postoperative pain management following hemorrhoidectomy. Among these techniques, pudendal nerve block has gained increasing attention because it provides targeted analgesia to the anal canal and perianal region while minimizing systemic adverse effects associated with opioid-based pain management. Previous randomized controlled trials and meta-analyses have demonstrated that pudendal nerve block can reduce postoperative pain intensity, decrease analgesic consumption, and improve postoperative recovery after anorectal surgery.

Traditionally, pudendal nerve block has been performed using anatomical landmarks identified by digital palpation of the ischial spine. Although this technique is widely used and does not require additional equipment, the success of the block depends largely on operator experience and anatomical variation. Inaccurate needle placement may reduce block efficacy and increase the risk of technical failure.

The introduction of ultrasound-guided regional anesthesia has enabled direct visualization of anatomical structures, including the internal pudendal vessels and surrounding soft tissues. Ultrasound guidance may improve needle placement accuracy, facilitate local anesthetic spread around the target nerve, and potentially reduce procedure-related complications. Several studies have reported favorable outcomes with ultrasound-guided pudendal nerve block; however, most available evidence compares pudendal nerve block with other anesthetic or analgesic techniques rather than directly comparing different pudendal block approaches.

Currently, there is limited prospective randomized evidence comparing ultrasound-guided and conventional landmark-guided pudendal nerve block techniques in patients undergoing hemorrhoidectomy. Therefore, the relative clinical advantages of ultrasound guidance in this setting remain uncertain.

This single-center, prospective, randomized, double-blind clinical trial has been designed to compare ultrasound-guided and landmark-guided bilateral pudendal nerve block techniques performed after Milligan-Morgan hemorrhoidectomy. The study seeks to determine whether ultrasound guidance provides clinically meaningful benefits in postoperative pain management and recovery when compared with the conventional landmark-guided approach. The results may contribute to the optimization of perioperative pain management strategies and help guide evidence-based selection of pudendal nerve block techniques in routine colorectal surgical practice.

02

Conditions studied

  • Hemorrhoids
  • Postoperative Pain
  • Pudendal Nerve Block

Keywords

  • Hemorrhoids
  • Hemorrhoidectomy
  • Pudendal Nerve Block
  • Postoperative Pain
  • Ultrasound-Guided Pudendal Nerve Block
  • Landmark-Guided Pudendal Nerve Block
  • Regional Anesthesia
  • Pain Management
03

In context

Hemorrhoids

226 studies on the registry are indexed under Hemorrhoids; 66 are open to participants now.

This study's planned enrollment of 80 is below the median of 97 across 173 interventional studies indexed under Hemorrhoids.

Browse Hemorrhoids studies →

Lead sponsor

Konya City Hospital is the lead sponsor of 78 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 65 years.
  • American Society of Anesthesiologists (ASA) physical status I or II.
  • Diagnosis of Grade III hemorrhoidal disease.
  • Scheduled to undergo Milligan-Morgan hemorrhoidectomy.
  • Ability to understand the study procedures and provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Previous anorectal surgery.
  • Chronic pelvic pain.
  • Vertebral or pelvic deformity that may interfere with the procedure.
  • Known coagulation disorders or anticoagulation contraindicating regional anesthesia.
  • Known allergy or hypersensitivity to lidocaine or bupivacaine.
  • Pregnancy or breastfeeding.
  • Refusal or inability to provide written informed consent.
  • Failed or technically unsuccessful pudendal nerve block.
  • Inability to complete postoperative outcome assessments.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Ultrasound-Guided Pudendal Nerve Block

    Participants undergoing Milligan-Morgan hemorrhoidectomy will receive bilateral ultrasound-guided pudendal nerve block after completion of surgery under spinal anesthesia. The block will be performed by an anesthesiologist using ultrasound guidance and a standardized local anesthetic mixture.

    Procedure: Ultrasound-Guided Pudendal Nerve Block

  • Active comparator
    Landmark-Guided Pudendal Nerve Block

    Participants undergoing Milligan-Morgan hemorrhoidectomy will receive bilateral landmark-guided pudendal nerve block after completion of surgery under spinal anesthesia. The block will be performed using digital palpation of the ischial spine and the same standardized local anesthetic mixture.

    Procedure: Landmark-Guided Pudendal Nerve Block

Interventions

  • ProcedureUltrasound-Guided Pudendal Nerve Block

    Bilateral pudendal nerve block performed under ultrasound guidance using a standardized mixture of 1% lidocaine and 0.25% bupivacaine following Milligan-Morgan hemorrhoidectomy.

  • ProcedureLandmark-Guided Pudendal Nerve Block

    Bilateral pudendal nerve block performed using anatomical landmarks identified by digital palpation of the ischial spine with the same standardized mixture of 1% lidocaine and 0.25% bupivacaine following Milligan-Morgan hemorrhoidectomy.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Intensity at 24 Hours

    Postoperative pain intensity will be assessed using a Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: 24 hours after surgery

Secondary outcomes

  1. Postoperative Pain Intensity at 6, 12, and 48 Hours

    Postoperative pain intensity will be assessed using a Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: 6, 12, and 48 hours after surgery

  2. Total Postoperative Analgesic Consumption

    Total rescue analgesic consumption during the first 48 hours after surgery will be recorded and compared between study groups.

    Time frame: Within 48 hours after surgery

  3. Incidence of Early Postoperative Complications

    The incidence of urinary retention and postoperative nausea and vomiting occurring during the first 48 hours after surgery will be recorded.

    Time frame: Within 48 hours after surgery

  4. Patient Satisfaction

    Patient satisfaction with postoperative pain management will be assessed at 48 hours after surgery using a 5-point Likert scale, with higher scores indicating greater satisfaction.

    Time frame: 48 hours after surgery

  5. Quality of Postoperative Recovery

    Quality of postoperative recovery will be assessed at 48 hours after surgery using the Quality of Recovery-15 (QoR-15) questionnaire. The questionnaire consists of 15 items, with a total score ranging from 0 to 150. Higher scores indicate better postoperative recovery.

    Time frame: 48 hours after surgery

07

Study locations

1 site
  • Konya City Hospital
    Konya, Konya 42020, Turkey (Türkiye)
08

References and documents

Publications

  • Imbelloni LE, Vieira EM, Gouveia MA, Netinho JG, Spirandelli LD, Cordeiro JA. Pudendal block with bupivacaine for postoperative pain relief. Dis Colon Rectum. 2007 Oct;50(10):1656-61. doi: 10.1007/s10350-007-0216-7. PubMed 17701375 ↗
  • Pan P, Jiang J, Zhang X, Yang W, Ding W. Ultrasound-guided pudendal nerve block for postoperative pain management in procedures for prolapse and hemorrhoids: a randomized, double-blinded trial. Int J Colorectal Dis. 2025 Jul 17;40(1):159. doi: 10.1007/s00384-025-04953-3. PubMed 40676415 ↗
  • Di Giuseppe M, Saporito A, La Regina D, Tasciotti E, Ghielmini E, Vannelli A, Pini R, Mongelli F. Ultrasound-guided pudendal nerve block in patients undergoing open hemorrhoidectomy: a double-blind randomized controlled trial. Int J Colorectal Dis. 2020 Sep;35(9):1741-1747. doi: 10.1007/s00384-020-03630-x. Epub 2020 May 30. PubMed 32474710 ↗
  • Xia S, Luo L, Wu W, Lu K, Jiang T, Li Y. The role of pudendal nerve block in hemorrhoid surgery: a systematic review and meta-analysis of double-blind randomized controlled trials. Front Med (Lausanne). 2023 Dec 13;10:1283512. doi: 10.3389/fmed.2023.1283512. eCollection 2023. PubMed 38152300 ↗
  • Mongelli F, Treglia G, La Regina D, Di Giuseppe M, Galafassi J, Majno-Hurst PE, Christoforidis D. Pudendal Nerve Block in Hemorrhoid Surgery: A Systematic Review and Meta-analysis. Dis Colon Rectum. 2021 May;64(5):617-631. doi: 10.1097/DCR.0000000000001985. PubMed 33591044 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07889869
Lead sponsor
Konya City Hospital
Responsible party
Gurcan Simsek (Associate Professor, Department of General Surgery, Konya City Hospital, Konya City Hospital) — Principal investigator
First posted
Oct 22, 2026
Start date
May 14, 2026
Primary completion
Jul 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Gürcan Şimşek, MD
principal investigator · Konya City Hospital, Ministry of Health, Republic of Türkiye

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion